With 0.93 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.89 million shares. The 52-week range on INMD shows that it touched its highest point at $23.38 and its lowest point at $14.87 during that stretch. It currently has a 1-year price target of $21.33. Beta for the stock currently stands at 1.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INMD was up-trending over the past week, with a rise of 3.98%, but this was up by 10.34% over a month. Three-month performance dropped to -0.69% while six-month performance rose 22.84%. The stock lost -16.84% in the past year, while it has gained 15.63% so far this year. A look at the trailing 12-month EPS for INMD yields 2.34 with Next year EPS estimates of 2.13. For the next quarter, that number is 0.38. This implies an EPS growth rate of 10.33% for this year and 9.89% for next year. EPS is expected to grow by 9.62% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 16.55%.
Float and Shares Shorts:
At present, 69.56 million INMD shares are outstanding with a float of 60.29 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INMD since 5 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $2.03801 being high and $1.80555 being low. For INMD, this leads to a yearly average estimate of $1.86356. Based on analyst estimates, the high estimate for the next quarter is $0.51 and the low estimate is $0.44. The average estimate for the next quarter is thus $0.48.
